Physician profile
Wesley Parker
NPI 1508350646
$31,880.31
in general payments reported to CMS, 2019-2025
10 companies · $450 in 2025
The $450 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $853 · 2021: $7,246 · 2022: $5,138 · 2023: $8,319 · 2024: $9,874 · 2025: $450.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $7,500 · Grant: $7,500 · Food and Beverage: $2,024 · Travel and Lodging: $1,619.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $7,500.00 |
| Grant | $7,500.00 |
| Food and Beverage | $2,023.79 |
| Travel and Lodging | $1,618.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $17,660.31 | 2023-2025 | Journey II, Or3o Dual Mobility, Legion Revision |
| Peerless Surgical INC. | $11,738.39 | 2019-2025 | |
| Zimmer Biomet Holdings, INC. | $2,155.08 | 2022-2023 | Persona, Rosa, Avenir |
| Amgen INC. | $122.55 | 2025 | Evenity |
| Depuy Synthes Sales INC. | $116.96 | 2024-2025 | Na, Truespan Orthocord, Speedtrap |
| Vericel Corporation | $21.86 | 2025 | Maci |
| Osteoremedies, LLC | $20.87 | 2025 | Biowash Surgical Irrigation |
| Ferring Pharmaceuticals INC. | $18.08 | 2025 | Euflexxa |
| Bioventus LLC | $16.84 | 2025 | Durolane |
| Ethicon US, LLC | $9.37 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wesley Parker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.